We are live on ! Find out more
Dmitry Balyasny

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B Turnover 42.78%
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
Cap. Flow
-$3.01B
Cap. Flow %
-3.76%
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.8 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.95%
2 Technology 12.69%
3 Industrials 9.95%
4 Consumer Discretionary 8.03%
5 Healthcare 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XLRE icon
1876
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.13B
$1.6M ﹤0.01%
+36,298
New +$1.6M
2026 Q2
0 quarters
GLNG icon
1877
CALL
Golar LNG
GLNG
$4.72B
$1.59M ﹤0.01%
+32,000
New +$1.69M
2026 Q2
0 quarters
MRNA icon
1878
PUT
Moderna
MRNA
$88.5B
$1.59M ﹤0.01%
+22,700
New +$1.17M
2026 Q2
0 quarters
CRMD icon
1879
CorMedix
CRMD
$444M
$1.59M ﹤0.01%
+202,370
New +$1.6M
2026 Q2
0 quarters
BRSL icon
1880
Brightstar Lottery PLC
BRSL
$1.75B
$1.58M ﹤0.01%
147,766
-354,902
-71% -$4.22M
2025 Q4
2 quarters
MRNA icon
1881
CALL
Moderna
MRNA
$88.5B
$1.58M ﹤0.01%
+22,600
New +$1.17M
2026 Q2
0 quarters
EWP icon
1882
iShares MSCI Spain ETF
EWP
$1.94B
$1.58M ﹤0.01%
26,640
+22,740
+583% +$1.3M
2026 Q1
1 quarter
TCOM icon
1883
PUT
Trip.com Group
TCOM
$24.9B
$1.58M ﹤0.01%
39,600
-100
-0.3% -$4.96K
2025 Q3
3 quarters
HE icon
1884
Hawaiian Electric Industries
HE
$1.51B
$1.58M ﹤0.01%
+116,476
New +$1.66M
2026 Q2
0 quarters
HLIO icon
1885
Helios Technologies
HLIO
$2.18B
$1.57M ﹤0.01%
+17,621
New +$1.35M
2026 Q2
0 quarters
SGML icon
1886
Sigma Lithium
SGML
$788M
$1.57M ﹤0.01%
124,025
-755,185
-86% -$12.7M
2025 Q2
4 quarters
BUSE icon
1887
First Busey Corp
BUSE
$2.38B
$1.56M ﹤0.01%
52,872
+29,832
+129% +$809K
2025 Q1
5 quarters
AUTL icon
1888
Autolus Therapeutics
AUTL
$405M
$1.56M ﹤0.01%
972,748
+1,057
+0.1% +$1.66K
2026 Q1
1 quarter
IOVA icon
1889
Iovance Biotherapeutics
IOVA
$3.84B
$1.55M ﹤0.01%
373,284
+124,520
+50% +$473K
2021 Q1
21 quarters
EEFT icon
1890
Euronet Worldwide
EEFT
$2.36B
$1.55M ﹤0.01%
21,197
-97,044
-82% -$6.77M
2026 Q1
1 quarter
PNC icon
1891
PUT
PNC Financial Services
PNC
$90.9B
$1.55M ﹤0.01%
+6,300
New +$1.41M
2026 Q2
0 quarters
IONQ icon
1892
CALL
IonQ
IONQ
$12.9B
$1.55M ﹤0.01%
29,100
-83,400
-74% -$4.23M
2025 Q2
4 quarters
KR icon
1893
PUT
Kroger
KR
$39.4B
$1.55M ﹤0.01%
27,900
-3,000
-10% -$196K
2026 Q1
1 quarter
TER icon
1894
CALL
Teradyne
TER
$42.8B
$1.55M ﹤0.01%
3,200
-6,600
-67% -$2.49M
2026 Q1
1 quarter
MNST icon
1895
PUT
Monster Beverage
MNST
$92.7B
$1.55M ﹤0.01%
32,200
+19,200
+148% +$807K
2025 Q1
5 quarters
KRE icon
1896
State Street SPDR S&P Regional Banking ETF
KRE
$4.3B
$1.55M ﹤0.01%
+20,647
New +$1.44M
2026 Q2
0 quarters
RIOT icon
1897
CALL
Riot Platforms
RIOT
$4.81B
$1.54M ﹤0.01%
56,300
-244,700
-81% -$5.52M
2025 Q1
5 quarters
MPWR icon
1898
Monolithic Power Systems
MPWR
$59.1B
$1.54M ﹤0.01%
1,115
+320
+40% +$480K
2025 Q3
3 quarters
HLIT icon
1899
Harmonic Inc
HLIT
$1.12B
$1.54M ﹤0.01%
+94,328
New +$1.2M
2026 Q2
0 quarters
JOYY icon
1900
JOYY Inc
JOYY
$3.93B
$1.54M ﹤0.01%
23,265
+14,129
+155% +$879K
2024 Q4
6 quarters

Similar funds

Dmitry Balyasny's Q2 2026 Portfolio in Review

As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.

  • Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
  • Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
  • Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
  • Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
  • Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
  • Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.